SOHO 2025 | The use of AI in hematologic malignancies: insights from a study comparing various approaches

Shivani Modi • 4 Sep 2025

SOHO 2025

General

Shivani Modi, MD, Jefferson Einstein Montgomery Hospital, Philadelphia, PA, discusses her work exploring the potential of artificial intelligence (AI) in hematologic malignancies, highlighting its ability to provide accurate and up-to-date information. She notes that AI-based tools can be effective in providing guidance, but ultimately, the expertise of a hematology attending is still necessary to consider individual patient factors. This interview took place at the 13th Annual Meeting of the Society of Hematologic Oncology (SOHO 2025) in Houston, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.